Vivasure $185 million exit an Interview with Andrew Glass, CEO
In this episode of The Crux of MedTech, host Henry Norton sits down with Andrew Glass, CEO of Vivasure Medical, fresh off announcing the company's acquisition by Haemonetics Corporation.
Andrew shares the full journey, from his early days in drug-eluting stents at Guidant (later Abbott), to running a $10M sales territory, to making equity investments at Abbott Ventures, and finally taking the leap to lead an Irish medtech startup through a US pivotal trial and strategic exit.
He discusses what it was really like to join a company with two months of cash, why products are never perfect the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.